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Abstract
Primary lung neoplasms are rare in children. The most common primary lung malignancies in children are pleuropulmonary 
blastoma and carcinoid tumour. Synovial sarcoma (SS) accounts for approximately 1% of all childhood malignancies. In absolute 
terms, the SS of the lungs and pleura are extremely rare and pose a diagnostic difficulty. Soft tissue sarcomas usually have 
a high potential for metastases, however, metastasis to the brain is rare, even in widely disseminated disease, and it has been 
described only in 3 case reports previously. Primary pleuropulmonary SS with brain metastases is even rarer. Here we present 
a case of an 11-year-old boy who presented with respiratory complaints, viz. fever and cough for 20 days. Initial impression 
was lung abscess, however, on histopathological, immunohistochemical and molecular study, the disorder was diagnosed as 
synovial sarcoma. After a week from the first consult, the child developed neurological symptoms, viz., an episode of convulsion 
and gradually worsening power of the lower limb. Computed tomography scan and Magnetic Resonance Spectroscopy was 
suggestive of brain metastases. Given the rarity of primary lung neoplasms in children, clinical detection remains a challenge. 
Delayed diagnoses are common as respiratory symptoms may be attributed to inflammatory or infective processes. Primary pleu-
ropulmonary synovial sarcoma is a rare tumour and it is not known to commonly metastasise to the brain. Though rare, primary 
pleuropulmonary SS should be considered an important differential among peadiatric primary lung neoplasms due to its potential 
for curability if detected early, and more aggressive metastatic pattern, e.g. brain metastases making early detection imperative.
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Introduction
Primary pleuropulmonary synovial sarcoma 
is an extremely rare tumour. Most of the primary 
lung malignancies are carcinomas. Sarcomas 
comprise only 0.5% of primary lung malignan-
cies [1, 2]. Soft tissue sarcomas have a very high 
tendency to metastasise, the most common site 
being the lung. The brain is a  rare location of 
metastases. Here we present a rare case of a child 
with primary pleuropulmonary synovial sarcoma 
with brain metastases.
Case report
An 11-year-old boy presented with the chief 
complaints of moderate grade intermittent fever, 
without chills and cough with scanty, non puru-
lent, watery expectoration for approximately 
20 days. Investigation by a  local paediatrician, 
chest X-ray (CXR) and ultrasonography (USG) of 
the thorax showed right lower zone consolidation 
with moderate pleural effusion. An intercostal 
drain was inserted and patient was referred to 
a multidisciplinary centre.
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Figure 1. A, B — CT scan of thorax showing pulmonary mass; C, D — MR spectroscopy findings  
A B
C D
According to records, at presentation, the 
child was normotensive but sick-looking with 
tachypnea and tachycardia. Saturation of ha-
emoglobin with oxygen was 96%. The patient 
was started on intravenous (iv) antibiotics and 
iv fluids. A complete haemogram, liver and renal 
function tests, and the results of blood cultures 
were within normal limits. 
A computed tomography (CT) scan of the 
thorax was done, which showed a large well-de-
fined multiloculated thin walled peripherally 
enhancing necrotic lesion (63 mm × 62 mm × 
76 mm) in the right middle and lower lobe with 
few air foci in between, suggesting the possibility 
of lung abscess or cystic metastases (Fig. 1A, B).
At the multidisciplinary centre; considering 
it lung abscess, a thoracoscopy with right poste-
rolateral thoracotomy was performed. Necrotic 
material from the right upper and middle lobe was 
drained, decortication of the pleura was done and 
a 24 French intercostal drain was kept in situ. The 
material was sent for routine exam, microbiological 
testing, culture and histopathological evaluation 
(HPE). HPE was suggestive of malignancy so pa-
tient was referred to our regional cancer centre. 
The histopathological diagnosis review was 
indicative of high grade sarcoma with spindle 
and epithelioid morphology, thus suggestive of 
biphasic synovial sarcoma (SS). Immunohistoche-
mistry (IHC) panel showed CD99, TLE-1, EMA, 
CK positivity while SAL4, SOX10, CD56, OCT3/4, 
desmin and myogenin were negative (Fig. 2 A–D). 
In the absence of cartilage in specimen and rela-
tively older age of the patient, the differential of 
pleuropulmonary blastoma was ruled out. 
A thorough search for primary disease of the 
extremities was done. Surgery was attempted 
to resect the primary lesion, but the lesion was 
extensive and involved the pleura and subcuta-
neous tissue. Thus only biopsy was taken which 
revealed high-grade synovial sarcoma. A repeat 
IHC panel showed vimentin, CD99, Bcl 2 positi-
vity, whereas desmin, actin, S-100, AE-1, synap-
tophysin were negative. The FFPE block was sent 
for FISH SS18 rearrangement, which was positive, 
hence confirming diagnosis of synovial sarcoma.
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 Figure 2. A — CD99 membranous positivity; B — TLE nuclear strong positivity; C — Vimentin cytoplasmic plus membranous positivity; D — BCl2 
nuclear positivity
A B
C D
After a week from the first consult, the child 
presented with an episode of convulsion and 
gradually worsening power in the left lower limb, 
which worsened from grade 4 to grade 2 within 
a span of 2 days. The child was started on anti 
cerebral oedema measures (injectable dexametha-
sone and mannitol) and anti-convulsant drugs. 
A contrast enhanced CT scan of the brain showed 
multiple peripherally enhancing hypodense ring 
enhancing lesions in the right frontal and parietal 
lobes, the largest measuring 31 mm × 41 mm with 
cerebral oedema and midline shift of 10 mm. 
In view of frugal literature suggesting synovial 
sarcoma metastasising to the brain, alternate dia-
gnoses, viz., tuberculoma, neurocysticercosis were 
considered. Magnetic resonance imaging with spec-
troscopy (MRS) of the brain was ordered, which 
showed elevated Cholin (Cho) level with mildly 
reduced N- acetylaspartate (NAA) level with the 
increase in the Cho/NAA and Cho/total creatine (Cr) 
ratio suggestive of neoplastic aetiology (Fig. 2C, D).
In view of circumstantial evidence, a dia-
gnosis of SS with brain metastases was made. 
Neurosurgery opinion was taken for assessment 
of resectability of brain metastases; however, 
complete resection of all intracranial lesions was 
not possible. 
Biopsy of the intracranial lesion was not 
contemplated as enough circumstantial eviden-
ce was gathered in the form of MRS findings 
which suggested neoplastic etiology; other 
factors taken into account were unstable neu-
rological status of the patient, aggressive nature 
of tumour and morbidity of the procedure. 
The patient was referred for whole brain 
irradiation. Radiotherapy with a total dose of 30 
Grays over 10 fractions was administered. The 
child recovered neurologically with grade 4 plus 
power, able to walk without support. Subsequen-
tly, he has been started on systemic chemotherapy 
with palliative intent comprising of single agent 
doxorubicin (25 mg/m2) for 3 days. The patient 
tolerated the first two cycles of chemotherapy 
very well, thus, ifosfamide (3 g/m2) for 3 days 
was added to doxorubicin. After total 4 cycles 
of chemotherapy, re-evaluation showed stable 
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pulmonary disease and partial response in brain 
metastases according to RECIST 1.1 guidelines. 
The patient has been ambulatory without support 
with minimal pulmonary symptoms, however, 
he had one episode of breakthrough convulsion.
Discussion
Primary lung neoplasms are rare in children. 
The common types of lung cancer in adults are 
exceptional occurrences in the paediatric popu-
lation. The ratio of primary tumours to metastatic 
to non-neoplastic lesions in pathologic changes 
arising from the lung in children is 1:5:60 [3]. The 
most common benign pulmonary tumour of the 
paediatric lung is inflammatory myofibroblastic 
tumour (52%), and the most common primary 
lung malignancies in children are pleuropulmo-
nary blastoma and carcinoid tumour [4]. 
Synovial sarcoma (SS) accounts for approxi-
mately 5-10% of all soft tissue sarcomas [5]. The 
incidence of SS is 2.75 per 100,000 individuals [6]. 
It is the disease of adolescents and young adults, 
the mean age of diagnoses being 35.4 years [7]. 
Most common sites of synovial sarcoma are the 
extremities especially the large joints; however, 
other locations, viz. head & neck, lung, mediasti-
num, and abdominal wall have been reported too. 
Synovial sarcoma accounts for approximately 1% 
of all childhood malignancies and despite its rari-
ty, is the most common non-rhabdomyosarcoma 
in childhood, making up approximately 30% of 
all soft tissue sarcomas [8–10].
In absolute terms, the SS of the lungs and the 
pleura are extremely rare [6, 7], and pose a dia-
gnostic difficulty. Review of literature shows only 
few case reports and small case series that report 
tumours of similar lineage [1, 11–13]. The English 
literature documents barely 60 cases of synovial 
sarcoma at pleuropulmonary region till 2005 [14]. 
Spurrell et al. [15] at Royal Marsden Hospital, 
London, between 1978 and 2003, presented analy-
sis of 104 cases of SS, out of which only 10 were 
pleuropulmonary in origin. Pleuropulmonary SS 
seem to be more aggressive as compared to their 
counterparts of the extremities with less chance 
of complete resection and difficulty to achieve 
adequate wide margins and hence high percen-
tage of local recurrence [16].
Soft tissue sarcomas usually have a high 
potential to metastasize. The most common site 
of metastases is the lung. One study showed a 
75:1 ratio of lung to liver metastases, as the site 
of distant spread, however, in this subset with 
hepatic metastases 22% had primary abdominal 
SS [17]. Similarly, metastasis to the brain is also 
rare, even in widely disseminated disease [18, 19], 
and it was reported only in 3 case reports pre-
viously [20]. Pleuropulmonary SS with brain 
metastases is even rarer with just one report men-
tioning brain metastases as a terminal event [21] 
and one by Nuwal et al. [22] reported in 2012. 
The both patients reported were adults and this is 
probably the first case, to the best of our knowled-
ge, in peadiatric age group and based on pubmed 
database search to date.
Histopathological variants of SS are bipha-
sic, monophasic epithelial, monophasic fibrous, 
poorly differentiated. The two main variants are 
the monophasic and the biphasic types. Biphasic 
pattern of synovial sarcoma consists of an ad-
mixture of glandular structures lined by cuboidal 
or columnar epithelium set in a  sarcomatous 
stroma [23].
Synovial sarcomas show a specific chromo-
somal translocation, t(X:18)(p11.2;q11.2), which 
results in fusion of the SYT gene on the long arm 
of chromosome 18 with the SSX1, SSX2 or SSX4 
gene on the short arm of the X chromosome. This 
is often helpful to make a diagnosis when SS arises 
from an unusual site, e.g. the pleura or the lung. 
Biphasic variants expresses, in most cases, SYT–
SSX1 gene fusion, while the monophasic type 
may express both (SYT–SSX1, SYT–SSX2) [24].
Synovial sarcoma demonstrates nuclear 
staining with TLE1 (transducin-like enhancer 
of split-1) in 95% of tumours and appears to 
be a very sensitive marker. TLE1 encodes for 
a  transcriptional co-repressor that is involved 
in epithelial and neuronal differentiation. In sy-
novial sarcoma there is usually co-expression of 
mesenchymal (vimentin) and epithelial markers 
(cytokeratin and EMA). Only synovial sarcoma is 
positive for cytokeratin 7 and 19, other soft tissue 
sarcomas show positivity for cytokeratin 8 and 
18; In monophasic synovial sarcoma immunore-
activity of cytokeratin is reduced by almost 60%; 
Cytokeratin positivity is noted in only 50% cases 
of PD synovial sarcoma while EMA positivity 
in 72% (more sensitive than cytokeratin), S100 
protein positivity in some cases, CD99 positivity 
in 2/3rd of cases and Bcl-2 positivity in most ca-
ses. [23–25]. The immunohistochemistry (IHC) 
panel in the above mentioned case showed CD99, 
TLE1, EMA, CK, vimentin, Bcl2 positivity. S100, 
however, was negative.
The standard care of synovial sarcoma inc-
ludes surgical resection with adequate free mar-
gins to prevent local recurrence followed with 
adjuvant chemotherapy with or without radiation. 
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In our patient, surgical resection of lung primary 
tumour could not be performed due to extensive 
involvement of adjacent structures. In view of 
neurosurgical resection being not possible, the 
boy received whole brain radiotherapy for bra-
in metastases and was subsequently started on 
palliative chemotherapy with single agent doxo-
rubicin (25 mg/m2 for 3 days). After 2 cycles of 
chemotherapy, in view of good tolerance, ifosfa-
mide (3g/m2 for 3 days) was added to doxorubicin 
along with appropriate supportive care as per the 
standard guidelines.  
Conclusions
Given the rarity of primary lung neoplasms in 
children, clinical detection remains a challenge. 
Delayed diagnoses are common as respiratory 
symptoms may be attributed to inflammatory 
or infective processes. Primary pleuropulmo-
nary synovial sarcoma, though rare, should be 
considered as an important differential among 
peadiatric primary lung neoplasms for its poten-
tial for curability if detected early. Also primary 
pleuropulmonary sarcoma is more aggressive and 
has different metastatic pattern, e.g. brain meta-
stases as in the above mentioned case; compared 
to synovial sarcoma arising from the extremities 
making early diagnosis imperative.
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